Before a Medical Test: What Questions Should Patients Ask?

Blood tests, imaging, endoscopy, biopsy and genetic testing can provide important information, but more testing does not automatically create better health knowledge. A test is most useful when it addresses a defined question and when its result could change what happens next.

A clinician may recommend a test to screen for disease before symptoms appear, investigate a symptom, confirm a diagnosis, determine disease extent or monitor treatment. Each purpose involves a different population, timing and interpretation. Understanding the purpose is often more important than remembering the test name alone.

Screening generally involves people without related symptoms who may benefit because of age or risk factors. Diagnostic testing evaluates an existing symptom, examination finding or previous abnormal result. Monitoring tracks a known condition, treatment response or recurrence risk.

The same test can have a different balance of benefits and harms depending on why it is used. A test appropriate for a high-risk population may not be useful for someone without symptoms and at low risk. A positive screening result also often requires additional testing before a diagnosis can be made.

No medical test is 100% accurate in every setting. A false positive suggests a condition is present when it is not. A false negative fails to detect a condition that is actually present.

The meaning of a result depends not only on test sensitivity and specificity, but also on symptoms, age, family history, medical history and the probability of disease before testing. When testing is expanded to people with a very low likelihood of disease, even a good test can produce positive findings that require confirmation.

Imaging may identify a nodule, cyst or other change unrelated to the original reason for testing. Many incidental findings are ultimately benign, but confirmation may involve repeat imaging, specialist visits, biopsy or long-term monitoring.

One test leading to another can be an appropriate and valuable diagnostic process. When the first test lacks a clear indication, however, the cascade may add anxiety, cost and risks from invasive procedures. Before testing, patients can ask what would usually happen if the result were abnormal or uncertain.

Risks vary substantially. A routine blood draw is generally low risk, while CT uses ionizing radiation, contrast-enhanced studies may involve contrast agents, and endoscopy, biopsy or other invasive procedures can involve bleeding, infection, anesthesia reactions or tissue injury.

Risk is not a reason to reject medically indicated testing. For a patient with symptoms, elevated risk or a decision that depends on the result, the information gained may substantially outweigh potential harms. The goal is to understand expected benefit, possible harm and alternatives in the context of the individual patient.

Whole-body scans, home tests and commercial genetic testing are increasingly available, but availability does not establish that a test is appropriate for every person or that the result can independently guide diagnosis or treatment. The FDA advises that direct-to-consumer results are only one part of a broader health picture and should not be the sole basis for medical decisions.

A negative commercial result does not replace recommended preventive screening or rule out disease when symptoms are present. A positive result often needs confirmation in a medical setting. For services not covered by insurance, patients should also ask whether follow-up image review, specialist care and additional testing could create further costs.

Patients can ask: What question is this test intended to answer? Why is it needed now? How could the result change diagnosis, treatment or follow-up? What are the risks of waiting or not testing? Is observation or another test a reasonable alternative?

They can also clarify the physical risks and preparation requirements, the possibility of false or incidental findings, what typically follows an abnormal or uncertain result, whether insurance authorization is needed and the expected out-of-pocket cost.

These questions are not a challenge to the clinician. They support shared decision-making. In an emergency or when serious disease is strongly suspected, prompt testing can be essential. The purpose of asking is to understand why the test matters and how its result will be used.

Laboratory reference ranges, radiology descriptions and pathology terminology require interpretation in the context of the test's purpose and the clinical picture. A mildly out-of-range value does not always indicate disease, and a result within range does not always exclude a problem.

After receiving a result, patients can ask whether it fits their symptoms or risk factors, whether and when it should be repeated, which warning signs require attention and whether specialist review is appropriate. International patients may also want to retain original images, pathology materials, the testing method and a complete English-language report for future consultation.

This article summarizes general information about medical testing and patient decision-making. It does not provide diagnosis, screening recommendations or individualized medical advice. Decisions to proceed with, delay or cancel a test should be discussed with appropriately qualified professionals who understand the patient's circumstances.